文献速递结核与非结核分枝杆菌艾滋病与性传播感染

丹麦HIV感染者结核病发病率与死亡率全国队列研究

Tuberculosis incidence and mortality in people living with human immunodeficiency virus: a Danish nationwide cohort study.
PubMed 文献 · Clin Microbiol Infect · 2021-08-24

结核发病随时间下降且与CD4恢复相关,但死亡率未改善。

要点

  • HIV感染者结核发病率总体为2.9/1000人年,移民显著高于本土出生者。
  • 非洲/亚洲/格陵兰来源、非法药物使用、CD4<200 cells/μL及未接受抗逆转录病毒治疗为独立结核风险因素。
  • TB诊断后死亡率为27.9/1000人年,随日历时间无改善。

核心结论

  • 晚期HIV合并结核仍是挑战,结核发病率随时间下降且与CD4恢复相关,强调早期成功抗逆转录病毒治疗的重要性。
  • 结核死亡率仍高,需在高风险人群中加强HIV和结核筛查策略及潜伏结核治疗。

研究设计与样本

  • 采用泊松回归估计结核发病率、全因死亡率及关联风险与预后因素。

主要发现

  • 共观察到217例结核事件,总发病率为2.9/1000人年(95% CI 2.6–3.4);移民为6.7/1000人年(95% CI 5.7–7.9),丹麦本土出生者为1.4/1000人年(95% CI 1.1–1.7),p < 0.001。
  • HIV诊断后>3个月诊断的结核发病率随日历时间、HIV诊断后时间延长和CD4细胞恢复而下降。
  • 独立结核风险因素:非洲来源aIRR 5.2(95% CI 3.5–7.6)、亚洲来源aIRR 6.5(95% CI 4.2–10.0)、格陵兰来源aIRR 7.0(95% CI 3.4–14.6)、非法药物使用aIRR 6.9(95% CI 4.2–11.2)、CD4 <200 cells/μL aIRR 2.7(95% CI 2.0–3.6)、未接受抗逆转录病毒治疗aIRR 3.7(95% CI 2.5–5.3)。
  • 死亡预后因素:丹麦来源aMRR 2.3(95% CI 1.3–4.3)、社会负担aMRR 3.9(95% CI 2.2–7.0)、结核诊断时CD4 <100 cells/μL aMRR 2.6(95% CI 1.3–4.9)、HIV诊断后>3个月诊断结核vs同时诊断aMRR 4.3(95% CI 2.2–8.7)、播散性结核aMRR 3.3(95% CI 1.1–9.9)。

临床怎么用

  • 对HIV感染者应尽早启动并维持成功的抗逆转录病毒治疗以促进CD4恢复,降低结核风险。
  • 对来自非洲、亚洲、格陵兰、有非法药物使用史或CD4低的HIV感染者加强结核筛查和潜伏结核治疗。
  • 晚期HIV合并结核患者死亡风险高,需关注社会负担、低CD4和播散性结核等预后因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To explore changes over time in the epidemiology of tuberculosis (TB) in Denmark in people living with human immunodeficiency virus (HIV) (PLWH). METHODS: In this nationwide, population-based cohort study we included all adult PLWH from the Danish HIV Cohort Study (1995-2017) without previous TB. We estimated TB incidence rate (IR), all-cause mortality rate (MR), associated risk and prognostic factors using Poisson regression. RESULTS: Among 6982 PLWH (73 596 person-years (PY)), we observed 217 TB events (IR 2.9/1000 PY, 95% CI 2.6-3.4: IR 6.7, 95% CI 5.7-7.9 among migrants and IR 1.4, 95% CI 1.1-1.7 among Danish-born individuals; p < 0.001). The IR of concomitant HIV/TB remained high and unchanged over time. The IR of TB diagnosed >3 months after HIV diagnosis declined with calendar time, longer time from HIV diagnosis, and CD4 cell recovery. Independent TB risk factors were African/Asian/Greenland origin (adjusted incidence rate ratio (aIRR) 5.2, 95% CI 3.5-7.6, aIRR 6.5, 95% CI 4.2-10.0, aIRR 7.0, 95% CI 3.4-14.6, respectively), illicit drug use (aIRR 6.9, 95% CI 4.2-11.2), CD4 <200 cells/μL (aIRR 2.7, 95% CI 2.0-3.6) and not receiving antiretroviral therapy (aIRR 3.7, 95% CI 2.5-5.3). Fifty-five patients died (MR 27.9/1000 PY, 95% CI 21.4-36.3), with no improvement in mortality over time. Mortality prognostic factors were Danish-origin (adjusted mortality rate ratio (aMRR) 2.3, 95% CI 1.3-4.3), social burden (aMRR 3.9, 95% CI 2.2-7.0), CD4 <100 cells/μL at TB diagnosis (aMRR 2.6, 95% CI 1.3-4.9), TB diagnosed >3 months after HIV versus concomitant diagnosis (aMRR 4.3, 95% CI 2.2-8.7) and disseminated TB (aMRR 3.3, 95% CI 1.1-9.9). CONCLUSION: Late HIV presentation with concomitant TB remains a challenge. Declining TB rates in PLWH were observed over time and with CD4 recovery, highlighting the importance of early and successful antiretroviral therapy. However, MR remained high. Our findings highlight the importance of HIV and TB screening strategies and treatment of latent TB in high-risk groups.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Martin-Iguacel R, Llibre JM, Pedersen C, et al. Tuberculosis incidence and mortality in people living with human immunodeficiency virus: a Danish nationwide cohort study. Clin Microbiol Infect. 2021. PMID: 34438070. doi:10.1016/j.cmi.2021.07.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。